Dumaldal, Baby Girl .
HRN: 23-66-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/24/2023
12/31/2023
IV INFUSION
21mg
Once
NEC
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes